Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05138796 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic Study of TP-05 in Healthy Subjects
A Phase 1 study, sponsored by Tarsus Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
NCT05138796 is a Phase 1 study that has completed, run by Tarsus Pharmaceuticals. The registered enrollment target is 67 participants.
The verdict
NCT05138796, a Phase 1 study, has completed, sponsored by Tarsus Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
Study Summary
A Phase 1, Randomized, Double-Blind, Single- and Multiple-Ascending Dose Study Evaluating the Safety, Tolerability, Food-Effect and Pharmacokinetics of TP-05 in Healthy Subjects
Interventions
- DRUG Placebo
- DRUG TP-05 (lotilaner oral capsules)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2021-05-06 |
| Est. Completion | 2022-07-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05138796
The ClinicalTrials.gov registry entry for NCT05138796 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tarsus Pharmaceuticals, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05138796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05138796 about?
NCT05138796 is a clinical study titled "A Pharmacokinetic Study of TP-05 in Healthy Subjects". A Phase 1, Randomized, Double-Blind, Single- and Multiple-Ascending Dose Study Evaluating the Safety, Tolerability, Food-Effect and Pharmacokinetics of TP-05 in Healthy Subjects
What is the current status of trial NCT05138796?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2021-05-06. Estimated completion is 2022-07-25.
What interventions are being tested in trial NCT05138796?
The interventions under investigation include: Placebo (DRUG), TP-05 (lotilaner oral capsules) (DRUG).
Who is sponsoring clinical trial NCT05138796?
This trial is sponsored by Tarsus Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.